Meta-analysis of the association between variants in SORL1 and Alzheimer disease.

OBJECTIVE To reexamine the association between the neuronal sortilin-related receptor gene (SORL1) and Alzheimer disease (AD). DESIGN Comprehensive and unbiased meta-analysis of all published and unpublished data from case-control studies for the SORL1 single-nucleotide polymorphisms (SNPs) that had been repeatedly assessed across studies. SETTING Academic research institutions in the United States, the Netherlands, Canada, Belgium, the United Kingdom, Singapore, Japan, Sweden, Germany, France, and Italy. PARTICIPANTS All published white and Asian case-control data sets, which included a total of 12,464 cases and 17,929 controls. MAIN OUTCOME MEASURES Alzheimer disease according to the Diagnostic and Statistical Manual of Mental Disorders (Fourth Edition) and the National Institute of Neurological and Communicative Disorders and Stroke and the Alzheimer's Disease and Related Disorders Association (now known as the Alzheimer's Association). RESULTS In the white data sets, several markers were associated with AD after correction for multiple testing, including previously reported SNPs 8, 9, and 10 (P < .001). In addition, the C-G-C haplotype at SNPs 8 through 10 was associated with AD risk (P < .001). In the combined Asian data sets, SNPs 19 and 23 through 25 were associated with AD risk (P < .001). The disease-associated alleles at SNPs 8, 9, and 10 (120,873,131-120,886,175 base pairs [bp]; C-G-C alleles), at SNP 19 (120,953,300 bp; G allele), and at SNPs 24 through 25 (120,988,611 bp; T and C alleles) were the same previously reported alleles. The SNPs 4 through 5, 8 through 10, 12, and 19 through 25 belong to distinct linkage disequilibrium blocks. The same alleles at SNPs 8 through 10 (C-G-C), 19 (G), and 24 and 25 (T and C) have also been associated with AD endophenotypes, including white matter hyperintensities and hippocampal atrophy on magnetic resonance imaging, cerebrospinal fluid measures of amyloid β-peptide 42, and full-length SORL1 expression in the human brain. CONCLUSION This comprehensive meta-analysis provides confirmatory evidence that multiple SORL1 variants in distinct linkage disequilibrium blocks are associated with AD.

[1]  Eden R Martin,et al.  Genome-wide association study implicates a chromosome 12 risk locus for late-onset Alzheimer disease. , 2009, American journal of human genetics.

[2]  G. Smith,et al.  Bias in meta-analysis detected by a simple, graphical test , 1997, BMJ.

[3]  Yaakov Stern,et al.  The association between genetic variants in SORL1 and Alzheimer disease in an urban, multiethnic, community-based cohort. , 2007, Archives of neurology.

[4]  K. Lunetta,et al.  Association of distinct variants in SORL1 with cerebrovascular and neurodegenerative changes related to Alzheimer disease. , 2008, Archives of neurology.

[5]  B. Hyman,et al.  Neuronal sorting protein-related receptor sorLA/LR11 regulates processing of the amyloid precursor protein. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[6]  J. H. Lee,et al.  ASSOCIATION BETWEEN GENETIC VARIANTS IN SORL1 AND AUTOPSY-CONFIRMED ALZHEIMER DISEASE , 2008, Neurology.

[7]  Y. Teo,et al.  SORL1 haplotypes modulate risk of Alzheimer's disease in Chinese , 2009, Neurobiology of Aging.

[8]  G. Hermey.  The Vps10p-domain receptor family , 2009, Cellular and Molecular Life Sciences.

[9]  M. Folstein,et al.  Clinical diagnosis of Alzheimer's disease , 1984, Neurology.

[10]  K. Sleegers,et al.  SORL1 is genetically associated with increased risk for late‐onset Alzheimer disease in the Belgian population , 2008, Human mutation.

[11]  C. DeCarli,et al.  Genetic correlates of brain aging on MRI and cognitive test measures: a genome-wide association and linkage analysis in the Framingham study , 2007, BMC Medical Genetics.

[12]  R. Mayeux,et al.  Possible Association between SORL1 and Alzheimer Disease? , 2008, Dementia and Geriatric Cognitive Disorders.

[13]  T. Kudo,et al.  SORL1 is genetically associated with Alzheimer disease in a Japanese population , 2009, Neuroscience Letters.

[14]  E. Génin,et al.  No replication of genetic association between candidate polymorphisms and Alzheimer's disease , 2011, Neurobiology of Aging.

[15]  P. Bosco,et al.  Genome-wide association study identifies variants at CLU and CR1 associated with Alzheimer's disease , 2009, Nature Genetics.

[16]  F. Jessen,et al.  Influence of SORL1 gene variants: Association with CSF amyloid-β products in probable Alzheimer's disease , 2008, Neuroscience Letters.

[17]  S. Small,et al.  Retromer sorting: a pathogenic pathway in late-onset Alzheimer disease. , 2008, Archives of neurology.

[18]  S. Leurgans,et al.  Neuronal LR11/sorLA expression is reduced in mild cognitive impairment , 2007, Annals of neurology.

[19]  H. Baba,et al.  Genetic Association between SORL1 Polymorphisms and Alzheimer’s Disease in a Japanese Population , 2008, Dementia and Geriatric Cognitive Disorders.

[20]  Y. Benjamini,et al.  Controlling the false discovery rate in behavior genetics research , 2001, Behavioural Brain Research.

[21]  K. Blennow,et al.  Sequence variation in SORL1 and dementia risk in Swedes , 2010, neurogenetics.

[22]  T. Montine,et al.  LR11/SorLA Expression Is Reduced in Sporadic Alzheimer Disease but not in Familial Alzheimer Disease , 2006, Journal of neuropathology and experimental neurology.

[23]  Thomas W. Mühleisen,et al.  Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer's disease , 2013, Nature Genetics.

[24]  N. Schupf,et al.  Association between genetic variants in sortilin-related receptor 1 (SORL1) and Alzheimer's disease in adults with Down syndrome , 2007, Neuroscience Letters.

[25]  M. Owen,et al.  SORL1 variants and risk of late-onset Alzheimer’s disease , 2008, Neurobiology of Disease.

[26]  J. Ioannidis,et al.  Quantitative Synthesis in Systematic Reviews , 1997, Annals of Internal Medicine.

[27]  M Krawczak,et al.  Examination of the current top candidate genes for AD in a genome-wide association study , 2010, Molecular Psychiatry.

[28]  A. J. Slater,et al.  Candidate single-nucleotide polymorphisms from a genomewide association study of Alzheimer disease. , 2008, Archives of neurology.

[29]  F. Jessen,et al.  Association of SORL1 gene variants with Alzheimer's disease , 2009, Brain Research.

[30]  S. DeKosky,et al.  No association of SORL1 SNPs with Alzheimer's disease , 2008, Neuroscience Letters.

[31]  D. Altman,et al.  Measuring inconsistency in meta-analyses , 2003, BMJ : British Medical Journal.

[32]  A. Hofman,et al.  A study of the SORL1 gene in Alzheimer's disease and cognitive function. , 2009, Journal of Alzheimer's disease : JAD.

[33]  P. S. St George-Hyslop,et al.  Association between SORL1 and Alzheimer's disease in a genome-wide study , 2007, Neuroreport.

[34]  F. Schmitt,et al.  Expression of SORL1 and a novel SORL1 splice variant in normal and Alzheimers disease brain , 2009, Molecular Neurodegeneration.

[35]  D. Stephan,et al.  Sorl1 as an Alzheimer’s Disease Predisposition Gene? , 2007, Neurodegenerative Diseases.

[36]  K. Lunetta,et al.  The neuronal sortilin-related receptor SORL1 is genetically associated with Alzheimer disease , 2007, Nature Genetics.

[37]  S. Sorbi,et al.  Implication of sex and SORL1 variants in italian patients with Alzheimer disease. , 2009, Archives of neurology.